Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Bonig, Halvard  [Clear All Filters]
2014
Kays S-K, Kaufmann KB, Abel T, Brendel C, Bonig H, Grez M, Buchholz CJ, Kneissl S. CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells. Stem Cells Dev. 2014.
2015
Pfirrmann V, Oelsner S, Rettinger E, Huenecke S, Bonig H, Merker M, Wels WS, Cinatl J, Schubert R, Klingebiel T, et al. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 2015.
Chow KUwe, Luxembourg B, Seifried E, Bonig H. Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals. Radiology. 2015:150887.
Schulz M, Karpova D, Spohn G, Damert A, Seifried E, Binder V, Bonig H. Variant rs1801157 in the 3'UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness. PLoS One. 2015;10(3):e0121859.
2016
Thiel U, Wawer A, von Luettichau I, Bender H-U, Blaeschke F, Grunewald TGP, Steinborn M, Röper B, Bonig H, Klingebiel T, et al. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget. 2016.
2019
Merker M, Salzmann-Manrique E, Katzki V, Huenecke S, Bremm M, Bakhtiar S, Willasch A, Jarisch A, Soerensen J, Schulz A, et al. Clearance of hematological malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions. Biol Blood Marrow Transplant. 2019.
Ortmann CA, Dorsheimer L, Abou-El-Ardat K, Hoffrichter J, Assmus B, Bonig H, Scholz A, Pfeifer H, Martin H, Schmid T, et al. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation. Cell Rep. 2019;27(7):2022-2028.e3.
Steiner M, Schneider L, Yillah J, Gerlach K, Kuvardina ON, Meyer A, Maring A, Bonig H, Seifried E, Zörnig M, et al. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation. PLoS One. 2019;14(1):e0210515.
Doberschuetz N, Soerensen J, Bonig H, Willasch A, Rettinger E, Pfirrmann V, Salzmann-Manrique E, Schäfer R, Klingebiel T, Bader P, et al. Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients. Transfusion. 2019.
Danner E, Hoffmann F, Lee S-Y, Cordes F, Orban S, Dauber K, Chudziak D, Spohn G, Wiercinska E, Tast B, et al. Modest and non-essential roles of the endocannabinoid system in immature hematopoiesis of mice. Exp Hematol. 2019.
2020
Kim-Wanner S-Z, Luxembourg B, Schmidt AH, Schäfer R, Möller N, Herbert E, Poppe C, Hümmer C, Bunos M, Seifried E, et al. Introduction of principles of blood management to healthy donor bone marrow harvesting. Vox Sang. 2020.
Jarisch A, Rettinger E, Sörensen J, Klingebiel T, Schäfer R, Seifried E, Bader P, Bonig H. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients. J Clin Apher. 2020.
2021
Bremm M, Krastel T, Cappel C, Zimmermann O, Pfeffermann L-M, Katzki V, Bonig H, Schäfer R, Rettinger E, Merker M, et al. Depletion of CD45RA T cells: Advantages and disadvantages of different purification methods. J Immunol Methods. 2021:112960.
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen CMathilde, Yeguas A, Vidriales M-B, González M, Saborido JRial, Kraus S, et al. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML). Blood. 2021.
2022
Jarisch A, Wiercinska E, Huenecke S, Bremm M, Cappel C, Hauler J, Rettinger E, Soerensen J, Hellstern H, Klusmann J-H, et al. Immune responses to SARS-CoV-2 vaccination in young patients with anti-CD19 CAR-T-induced B-cell aplasia. Transplant Cell Ther. 2022.
Saini SKumar, Holmberg-Thydén S, Bjerregaard A-M, Unnikrishnan A, Dorfmüller S, Platzbecker U, Tirado-Gonzalez I, Bonig H, Fassi DEl, Grønbæk K, et al. Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies. Leukemia. 2022.
2023
Wiercinska E, Quade-Lyssy P, Hümmer C, Beifuß J, Akarkach K, Poppe C, Olevska V, Dzionek J, Lahnor H, Bosio A, et al. Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product. J Transl Med. 2023;21(1):849.
Bader P, Rossig C, Hutter M, Ayuk FAyuketang, Baldus CD, Bücklein VL, Bonig H, Cario G, Einsele H, Holtick U, et al. CD19-CAR-T cells are an effective therapy of post-transplant relapse in B- ALL patients: Real-World Data from Germany. Blood Adv. 2023.
Seebach C, Nau C, Henrich D, Verboket R, Bellen M, Frischknecht N, Moeck V, Eichler K, Horlohé KHajo Schmi, Hoffmann R, et al. Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells for bone Augmentation of Plate-Stabilized Proximal Humeral Fractures - A Multicentric, Randomized, Open Phase IIa study. Stem Cells Transl Med. 2023.
Bonig H, Verbeek M, Herhaus P, Braitssch K, Beutel G, Schmid C, Müller N, Bug G, Döring M, von Stackelberg A, et al. Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. J Transl Med. 2023;21(1):837.
Jarisch A, Bonig H. Response to Haspel and McKenna 'Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk'. Br J Haematol. 2023.
2024
Kuci Z, Piede N, Vogelsang K, Pfeffermann L-M, Wehner S, Salzmann-Manrique E, Stais M, Kreyenberg H, Bonig H, Bader P, et al. Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?. J Transl Med. 2024;22(1):39.